Find uplifting stories about heroes, innovations, and solutions
7 results for "semaglutide"
Semaglutide, the active ingredient in Ozempic and Wegovy, helped people with obesity reduce heavy drinking days by 41% in a groundbreaking six-month trial. This marks the first randomized study testing GLP-1 drugs for alcohol use disorder treatment.
Scientists discovered that semaglutide, the drug behind Ozempic and Wegovy, can rebuild damaged cartilage in people with arthritis even without weight loss. The breakthrough hints at a powerful new treatment for millions suffering from joint pain.
New research reveals genetic variants that explain why weight-loss drugs like semaglutide help some people lose 25% of their body weight while others see minimal results. The discovery could pave the way for more personalized treatments.
Weight loss drug semaglutide shows unexpected mental health benefits in 100,000-person study. Depression, anxiety, and addiction rates plummeted during treatment periods.
A breakthrough study of 95,000 patients found that semaglutide, the active ingredient in Ozempic and Wegovy, significantly reduces the risk of worsening mental health in people with diabetes and depression. The discovery could offer hope for millions living with both conditions.
Researchers have created the first sex-specific brain map showing where popular weight-loss drugs like semaglutide work differently in females versus males. This breakthrough could explain why women often respond better to these treatments and pave the way for more personalized medicine.
More people with obesity are getting treatment now than at any point in the past 20 years, thanks to breakthrough medications like semaglutide. A major study tracking over 200,000 patients shows how policy changes and new drugs transformed access to life-changing care.